The Gene Amplification Technology Market is expected to grow from USD 2.78 billion in 2019 to USD 3 billion by 2026 at a CAGR of 4% from 2020 to 2026.
A wide-ranging analysis of the Gene Amplification Technologies market is offered in this report, alongside a brief overview of the segments in the Gene Amplification Technologies industry. The competitive landscape section of the Gene Amplification Technologies Market report offers a clear insight into the market share analysis of key industry players. Vital information regarding important competitors in this industry is trained in the report. Moreover, details regarding regions that have received the highest returns are also merged. The global gene amplification technologies market is anticipated to rise over the estimated period owing to the rising need for genetic information for the purpose of identifying and mapping all the genes of the human genome. Key drivers for the growth of gene amplification technology industry are rising R&D in the field of molecular diagnostics, genetic testing, biological research, drug discovery, environmental monitoring, bioremediation, toxicology, animal husbandry, quality control in the food industry and forensics. The global market is segregated on the basis of Application as Identity, Food safety, Agri-Diagnostics, Veterinary, Medical Applications, Forensics, and Paternity. Based on Technology the global market is segmented in Isothermal Signal Amplification, Cycling Temperature Signal Gene Amplification, Exponential Gene Amplification, Linear Gene Amplification, Target Amplification, Signal Amplification, Isothermal DNA Amplification, and Cycling Temperature DNA Amplification.
The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Gene Amplification Technology market has been segmented as below:
By Application
By Technology
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., and others.
Why Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Identity
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Food safety
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Agri-Diagnostics
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Veterinary
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Medical Applications
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Forensics
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Paternity
5.8.1 Market Overview
5.8.2 Market Size and Forecast
6.1 Introduction
6.2 Isothermal Signal Amplification
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Cycling Temperature Signal Gene Amplification
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Exponential Gene Amplification
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Linear Gene Amplification
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Target Amplification
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Signal Amplification
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 Isothermal DNA Amplification
6.8.1 Market Overview
6.8.2 Market Size and Forecast
6.9 Cycling Temperature DNA Amplification
6.9.1 Market Overview
6.9.2 Market Size and Forecast
7.1 Introduction
7.2 Europe
7.2.1 Europe Market, By Application
7.2.2 Europe Market, By Technology
7.3 North America
7.3.1 North America Market, By Application
7.3.2 North America Market, By Technology
7.4 Asia Pacific
7.4.1 Asia Pacific Market, By Application
7.4.2 Asia Pacific Market, By Technology
7.5 Rest of The World
7.5.1 Rest of The World Market, By Application
7.5.2 Rest of The World Market, By Technology
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9.1 Merck KGaA
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 PerkinElmer Inc.
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 QIAGEN Group
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Siemens Healthineers AG
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Thermo Fisher Scientific Inc.
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Agilent Technologies Inc.
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 bioMérieux SA
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Bio-Rad Laboratories Inc.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 F. Hoffmann-La Roche Ltd.
&nb
By Application
By Technology